NASDAQ · CADL
Candel Therapeutics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CADL: Nov 12, 2026
Candel Therapeutics, Inc. Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.3. The reported EPS for the same quarter last year was $-0.21.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.30 | $-0.22 | $-0.35 | 4 |
| Dec 2026 | $-0.33 | $-0.30 | $-0.36 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Barchart · Zacks · MarketBeat- RTTNews · Oct 1, 11:16 AM EDTCandel's Aglatimagene Shows Prolonged Survival In Phase 2a NSCLC Trial(RTTNews) – Thursday, Candel Therapeutics (CADL) reported final Phase 2a data for aglatimagene besadenovec plus valacyclovir in patients with unresectable Stage III/IV non-small cell lung cancer (NSCLC) who had an inadequate response to immune checkpoint inhibitors (ICIs).
- RTTNews · Oct 1, 11:03 AM EDTCandel Reports 24.5-Month Survival In Phase 2a NSCLC Study(RTTNews) – Candel Therapeutics (CADL) reported final Phase 2a results showing a median overall survival of 24.5 months with aglatimagene besadenovec plus valacyclovir in patients with advanced NSCLC who had an inadequate response to immune checkpoint inhibitors.
- Barchart · Sep 22, 1:51 PM EDTStocks Settle Sharply Higher as Crude Prices Plunge and Chipmakers SoarThe S&P 500 Index ($SPX ) (SPY ) closed up by +1.49% on Monday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.83%. December E-mini S&P futures (ESZ26 ) rose +1.50%, and December E-mini…
- Barchart · Sep 21, 6:40 PM EDTStocks Supported by Lower Crude Prices and Bond YieldsThe S&P 500 Index ($SPX ) (SPY ) is up by +0.61% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.33%. December E-mini S&P futures (ESZ26 ) are up +0.70%, and December E-mini…
- Barchart · Sep 21, 6:29 PM EDTStocks and Bonds Climb as Slumping Crude Prices Ease Inflation RisksThe S&P 500 Index ($SPX ) (SPY ) is up by +0.93% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.97%. December E-mini S&P futures (ESZ26 ) are up +1.00%, and December E-mini…
- Zacks · Sep 16, 5:47 AM EDTThe Zacks Analyst Blog Highlights Pfizer, Novartis, Candel and JanuxProstate cancer awareness spotlights Pfizer's Xtandi, Novartis' Pluvicto and clinical-stage programs from Candel and Janux.
- Zacks · Sep 15, 10:12 AM EDT4 Prostate Cancer Drug Stocks to Watch During Awareness MonthPfizer, Novartis, Janux Therapeutics and Candel Therapeutics offer varied prostate-cancer exposure, with established drugs and clinical or regulatory catalysts.
- RTTNews · Sep 11, 2:15 AM EDTCandel Therapeutics Adds Regulatory Executive Martine Zimmermann To Board As BLA Filing Nears(RTTNews) – Candel Therapeutics, Inc. (CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies, announced the appointment of Martine Zimmermann, PharmD, to the company's Board effective September 8, 2026.
- RTTNews · Aug 28, 11:38 AM EDTShow Me The Money: CADL Delivers 190%+ Gain In Less Than Six Months As BLA Filing Nears(RTTNews) – It has been a year of meaningful execution for Candel Therapeutics Inc. (CADL), marked by important clinical milestones, regulatory progress, and growing momentum across its pipeline.
- RTTNews · Aug 28, 5:57 AM EDTBiotech Stocks At 52-Week Highs – NEO, BLSM, RVMD, ORMP, CADL(RTTNews) – The following biotech stocks reached a 52-week high on August 27, 2026, driven by key catalysts like various regulatory milestones.
- RTTNews · Aug 14, 4:21 AM EDTBiotech Stocks At 52-Week Highs – PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG(RTTNews) – The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.
- MarketBeat · Aug 12, 1:04 PM EDTCandel Therapeutics Eyes 2026 Prostate Cancer Filing as Lung Study Ramps UpUnusually High Volume Points to Upside in These StocksCandel Therapeutics (NASDAQ:CADL) is advancing two off-the-shelf viral immunotherapy candidates designed for local administration intended to generate systemic immune responses against tumors, Chief Scientific Officer Francesc
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Candel Therapeutics, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.